Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

AKAP9 Antikörper (AA 1075-1125)

AKAP9 Reaktivität: Human WB, IP Wirt: Kaninchen Polyclonal unconjugated
Produktnummer ABIN7451618
  • Target Alle AKAP9 Antikörper anzeigen
    AKAP9 (A Kinase (PRKA) Anchor Protein (Yotiao) 9 (AKAP9))
    Bindungsspezifität
    • 5
    • 3
    • 2
    • 2
    • 1
    • 1
    • 1
    AA 1075-1125
    Reaktivität
    • 22
    • 3
    • 2
    • 2
    • 2
    • 2
    • 1
    • 1
    Human
    Wirt
    • 17
    • 3
    • 2
    Kaninchen
    Klonalität
    • 19
    • 3
    Polyklonal
    Konjugat
    • 12
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    Dieser AKAP9 Antikörper ist unkonjugiert
    Applikation
    • 10
    • 9
    • 6
    • 2
    • 1
    • 1
    Western Blotting (WB), Immunoprecipitation (IP)
    Verwendungszweck
    Rabbit anti-AKAP9/CG-NAP Antibody, Affinity Purified
    Aufreinigung
    Affinity Purified
    Immunogen
    between AA 1075 and 1125
    Isotyp
    IgG
    Top Product
    Discover our top product AKAP9 Primärantikörper
  • Applikationshinweise

    IP: 2 - 5 μg/mg lysate

    WB: 1:2,000 - 1:10,000

    Beschränkungen
    Nur für Forschungszwecke einsetzbar
  • Konzentration
    1000 μg/mL
    Buffer
    Tris-citrate/phosphate buffer, pH 7 to 8 containing 0.09 % Sodium Azide
    Konservierungsmittel
    Sodium azide
    Vorsichtsmaßnahmen
    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
    Lagerung
    4 °C
    Haltbarkeit
    12 months
  • Target
    AKAP9 (A Kinase (PRKA) Anchor Protein (Yotiao) 9 (AKAP9))
    Andere Bezeichnung
    AKAP9/CG-NAP (AKAP9 Produkte)
    Synonyme
    AKAP-9 antikoerper, AKAP350 antikoerper, AKAP450 antikoerper, CG-NAP antikoerper, HYPERION antikoerper, LQT11 antikoerper, MU-RMS-40.16A antikoerper, PPP1R45 antikoerper, PRKA9 antikoerper, YOTIAO antikoerper, 5730481H23Rik antikoerper, AW545847 antikoerper, C79026 antikoerper, mKIAA0803 antikoerper, Gisp antikoerper, Yotiao antikoerper, AKAP9 antikoerper, wu:fj02h02 antikoerper, prka9 antikoerper, yotiao antikoerper, akap350 antikoerper, akap450 antikoerper, hyperion antikoerper, AKAP120 antikoerper, A-kinase anchoring protein 9 antikoerper, A kinase (PRKA) anchor protein (yotiao) 9 antikoerper, A kinase (PRKA) anchor protein 9 antikoerper, A-kinase anchoring protein AKAP120 antikoerper, AKAP9 antikoerper, Akap9 antikoerper, akap9 antikoerper, CpipJ_CPIJ006715 antikoerper, CpipJ_CPIJ017436 antikoerper
    Hintergrund
    Background: AKAP9/CG-NAP is a member of the A-kinase anchoring protein family that functions as a molecular scaffold for the subcellular compartmentalization of A- kinase signaling molecules. AKAP9/CG-NAP has been found to be critical to repolarization in the human heart. Defects in AKAP9/CG-NAP result in long QT syndrome type 11, a heart disorder characterized by ventricular arrhythmia and prolonged QT intervals. AKAP9/CG-NAP has been shown to form a multiprotein complex with the I(Ks) potassium channel subunit and play an essential role in its phosphorylation by PKA. AKAP9/CG-NAP is also important to centrosome and microtubule cytoskeletal organization.
    Gen-ID
    10142
    NCBI Accession
    NP_671700
    UniProt
    Q99996
    Pathways
    M Phase, SARS-CoV-2 Protein Interaktom
Sie sind hier: